Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrand Architek. Regulatory News (BAR)

  • This share is currently suspended. It was suspended at a price of 47.50
  • There is currently no data for BAR

Trading Update

8 Jul 2015 07:00

RNS Number : 4260S
Swallowfield PLC
08 July 2015
 

Swallowfield plc

("Swallowfield" or the "Company")

 

Trading Update

 

Swallowfield plc, a market leader in the development, formulation, and supply of personal care and beauty products; whose customers include many of the world's leading brands, today provides an update on trading for the year ending 30th June 2015.

 

Trading

 

The board is pleased to announce that we anticipate full year profitability to be in line with market expectations.

 

Overall revenues for the full year are expected to show growth of 2.7% on a constant currency basis, 0.8% as reported versus the comparable 52 week period in the prior year (the year ended 30th June 2014 was a 53 week year). We have seen a slight softness in revenues versus expectations, due to the delayed availability of some materials and the continuing effect of the weak euro.

 

The Group has made good progress on its strategic pillar of Product Category Focus which has helped improve contribution margin.

 

Our balance sheet also continues to strengthen with tight control of inventories and cash leading to a net debt position of £5.4m, net of the outflow of £1.2m on the acquisition of 'The Real Shaving Company' brand. Adjusted for this, net debt of £4.2m compares favourably to the prior year at £5.1m.

 

Strategic Development

 

The recently acquired brand 'The Real Shaving Company' has now been successfully integrated into the business ahead of schedule. Customer response to our innovation plans for the brand have been very positive.

 

Development of our own Swallowfield brands continues to progress well. First orders of our premium beauty brand, 'Bagsy', have been shipped in recent weeks and distribution of our value brand 'Tru' has been extended.

 

Our premium and innovative new male haircare brand has also been positively received by major retailers, and will be launched in the autumn,

 

Outlook

 

We expect the challenging retail market conditions currently being experienced in the UK and Europe to persist in the medium term. However, the Board remains confident that the new strategy outlined last year will continue to gain further momentum, improve profitability and build shareholder value. In addition, this year we expect to benefit from further efficiencies, and improved run rate profitability, tighter control of working capital and new product developments already progressed in the 2014/15 financial year.

 

The Company expects to announce its results for the year ended 30th June 2015 on 22nd September 2015.

 

 

For further information please contact:

Swallowfield plctest

Chris How Chief Executive Officer 01823 662 241

Mark Warren Group Finance Director 01823 662 241

 

Nic Hellyer/

Jen Boorer/James Maxwell N+1 Singer 020 7496 3000

Alan Bulmer Investor Focus International 07831 654744

Chris Lawrance JBP Public Relations 0117 907 3400

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTRRMATMBMMBMA
Date   Source Headline
13th Apr 20225:19 pmRNSForm 8.3 - Brand Architekts Group PLC
13th Apr 20224:03 pmRNSForm 8.3 - Offeree - InnovaDerma PLC
13th Apr 20223:22 pmGNWForm 8.3 - Brand Architekts Group plc
13th Apr 20229:26 amRNSForm 8.3 - Brand Architekts Group Plc
13th Apr 20228:48 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
12th Apr 20223:21 pmRNSForm 8.3 - Brand Architekts Group plc - Replace
12th Apr 20222:04 pmRNSForm 8.5 (EPT/RI)
12th Apr 20229:34 amRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:18 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:17 pmRNSForm 8.3 - Brand Architekts Group plc
11th Apr 20226:14 pmRNSForm 8 (OPD) InnovaDerma PLC
11th Apr 20226:10 pmRNSForm 8 (OPD) - Brand Architekts plc
11th Apr 20224:04 pmRNSForm 8.3 - Brand Architekts Group PLC
11th Apr 20229:06 amRNSForm 8.5 (EPT/RI)
8th Apr 20225:15 pmRNSForm 8.3 - Brand Architekts Group PLC
8th Apr 202210:31 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
7th Apr 20222:40 pmRNSForm 8.4 - Roger McDowell
7th Apr 20222:40 pmRNSDirector/PDMR Shareholding
7th Apr 20229:53 amRNSForm 8.5 (EPT/RI)
6th Apr 20221:10 pmRNSForm 8.4 - Roger McDowell
6th Apr 20221:00 pmRNSDirector/PDMR Shareholding
6th Apr 202211:00 amRNSForm 8.3 - Brand Architekts Group PLC
6th Apr 202210:56 amRNSForm 8.5 (EPT/RI)
5th Apr 202211:45 amRNSForm 8.5 (EPT/RI)
4th Apr 202211:18 amRNSForm 8.5 (EPT/RI)
1st Apr 20221:40 pmRNSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
1st Apr 202211:53 amRNSForm 8.5 (EPT/RI) - Brand Architekts Group PLC
31st Mar 20222:54 pmRNSForm 8.3 - Brand Architekts Group Plc
31st Mar 20221:26 pmGNWForm 8.3 - Octopus Investments - Brand Architekts Group plc
31st Mar 20229:52 amBUSForm 8.3 - BRAND ARCHITEKTS GROUP PLC
31st Mar 20227:01 amRNSRecommended Merger with InnovaDerma Plc
31st Mar 20227:00 amRNSHalf-year Report
1st Mar 20227:00 amRNSBoard Appointment
14th Feb 202210:07 amRNSHolding(s) in Company
6th Dec 20214:01 pmRNSHolding(s) in Company
6th Dec 20213:56 pmRNSHolding(s) in Company
29th Nov 20213:54 pmRNSResult of AGM
4th Nov 20213:25 pmRNSAnnual Report and Accounts & Notice of AGM
12th Oct 202112:40 pmRNSGrant of Options
6th Oct 20213:51 pmRNSHolding(s) in Company
5th Oct 202111:23 amRNSHolding(s) in Company
4th Oct 20212:31 pmRNSHolding(s) in Company
30th Sep 202110:23 amRNSLaunch of marketplace: The Unexpekted Store
28th Sep 20212:56 pmRNSDirector/PDMR Dealing
28th Sep 20217:00 amRNSFinal Results
16th Sep 20217:00 amRNSNotice of Investor Presentation
20th Jul 20217:00 amRNSTrading Update
2nd Jul 202110:57 amRNSHolding(s) in Company
29th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20214:25 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.